Soligenix Inc (SNGX)

OTC : Health Care
Prev Close 2.20
Day Low/High 2.20 / 2.27
52 Wk Low/High 2.90 / 14.40
Avg Volume 178.60K
Exchange OTC
Shares Outstanding 5.72M
Market Cap 12.59M
EPS -6.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Soligenix Receives Additional NIAID Funding To Advance Development Of Heat Stable Ricin Vaccine

Awarded $2M to Advance Preclinical Efficacy Studies

Soligenix Announces Publication Of Its Phase 2 Long-term Follow-up Results Of SGX942 For The Treatment Of Oral Mucositis In Head And Neck Cancer Patients

At 12 Months SGX942 Found to be Safe and Well Tolerated with Multiple Potential Ancillary Benefits

Soligenix Receives Japanese Patent For ThermoVax® Vaccine Heat Stabilization Platform Technology

Patent describes application of ThermoVax® with RiVax®

Soligenix Announces Recent Accomplishments And Year-End 2016 Financial Results

Highlighted by Revenues of $10.4 Million

EMC Buys $6.4M More of VMware

EMC Corp buys another 90,000 shares.

CEO Sells $6.1M Worth of Liberty Media

Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.

TheStreet Quant Rating: E+ (Sell)